CH507-9B2.3 | | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CBS | Cystathionine-beta-synthase | Predicted intracellular proteins
| | | | | Tissue enhanced |
U2AF1 | U2 small nuclear RNA auxiliary factor 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP5J | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 | Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT8 | Chaperonin containing TCP1, subunit 8 (theta) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SOD1 | Superoxide dismutase 1, soluble | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MIS18A | MIS18 kinetochore protein A | Predicted intracellular proteins
| | | | | Expressed in all |
GART | Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SON | SON DNA binding protein | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
RUNX1 | Runt-related transcription factor 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Mixed |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBR3 | Carbonyl reductase 3 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
BRWD1 | Bromodomain and WD repeat domain containing 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
HMGN1 | High mobility group nucleosome binding domain 1 | Predicted intracellular proteins
| | | | | Mixed |
SH3BGR | SH3 domain binding glutamate-rich protein | Predicted intracellular proteins
| | | | | Group enriched |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TFF1 | Trefoil factor 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
U2AF1 | U2 small nuclear RNA auxiliary factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PDXK | Pyridoxal (pyridoxine, vitamin B6) kinase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
UBE2G2 | Ubiquitin-conjugating enzyme E2G 2 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PTTG1IP | Pituitary tumor-transforming 1 interacting protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MCM3AP | Minichromosome maintenance complex component 3 associated protein | Predicted intracellular proteins
| | | | | Expressed in all |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins
| | | | | Group enriched |